Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2007-12-21Clinical Trial Update: Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia [Phase 1, Phase 2]
An update on a phase 1/2 clinical trial evaluating liposomal annamycin in patients with refractory or relapsed acute lymphoblastic leukemia,…
-
CLINICAL_TRIALS research · 2007-12-03Clinical Trial Update: Adipokines as Predictors of the Metabolic Syndrome in ALL Survivors
The trial update investigates whether adipokines can predict metabolic syndrome in survivors of acute lymphoblastic leukemia. No interventio…
-
CLINICAL_TRIALS trial_result · 2007-11-02Clinical Trial Update: Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children
Completed clinical trial investigating pulmonary function at presentation and during follow-up in children aged 3-7 years with hematologic c…
-
CLINICAL_TRIALS trial_result · 2007-10-01Clinical Trial Update: Adult ALL Treatment at Diagnosis [NA]
A completed clinical trial update on treatment at diagnosis for adults with acute lymphoblastic leukemia.
-
FDA approval · 2007-09-13FDA Approved: GLEEVEC — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA supplemental application submitted for GLEEVEC (imatinib mesylate) by Novartis Pharmaceuticals Corporation.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2007-09-06Clinical Trial Update: Functional Pharmacogenomics of Childhood Acute Lymphoblastic Leukemia in Taiwan
Clinical trial update focusing on functional pharmacogenomics in childhood acute lymphoblastic leukemia in Taiwan. The current status of the…
-
CLINICAL_TRIALS trial_result · 2007-08-21Clinical Trial Update: ProphyALL - Study on the Safety of Liposomal Amphotericin B to Prevent Antifungal Infections in Elderly Patients With Acute Lymphoblastic Leukemia [Phase 4]
A Phase 4 trial evaluating the safety of liposomal amphotericin B to prevent fungal infections in elderly patients with acute lymphoblastic …
-
CLINICAL_TRIALS trial_result · 2007-07-23Clinical Trial Update: Urban Environmental Exposures and Childhood Cancer
A Georgetown University–sponsored trial investigating urban environmental exposures and childhood cancer has completed enrollment; the study…
-
CLINICAL_TRIALS trial_result · 2007-06-06Clinical Trial Update: Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III [Phase 3]
Phase 3 clinical trial evaluating treatment for adults with high-risk and/or low-risk acute lymphoblastic leukemia has completed.
-
FDA approval · 2007-04-30FDA Approved: METHOTREXATE — Original Application (Accord Healthcare, Inc.)
The FDA approved Accord Healthcare's original application for Methotrexate (generic).
-
CLINICAL_TRIALS trial_result · 2007-04-12Clinical Trial Update: Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers [Phase 1, Phase 2]
Completed Phase 1/2 clinical trial assessing infusion of ex vivo treated umbilical cord blood stem cells following chemoradiation in patient…
-
CLINICAL_TRIALS trial_result · 2007-04-06Clinical Trial Update: Osteoporosis in Children With ALL
This clinical trial update notes the completion of a study evaluating osteoporosis in children with acute lymphoblastic leukemia (ALL).
-
CLINICAL_TRIALS trial_result · 2006-12-14Clinical Trial Update: Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute Lymphoblastic Leukemia [Phase 4]
Phase 4 clinical trial update describing pulses of vincristine and dexamethasone in BFM protocols for children with acute lymphoblastic leuk…
-
CLINICAL_TRIALS research · 2006-11-22Clinical Trial Update: DHPLC Determination of TPMT Polymorphisms.
Clinical trial update describing a DHPLC method for determining TPMT polymorphisms, potentially informing thiopurine dosing in acute lymphob…
-
FDA approval · 2006-10-19FDA Approved: GLEEVEC — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for GLEEVEC (imatinib mesylate) submitted by Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2006-10-13Clinical Trial Update: A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients. [Phase 2, Phase 3]
The document provides an update on a randomized trial comparing somatropin (human growth hormone) to placebo in intensively treated hematolo…
-
FDA approval · 2006-07-24FDA Approved: ONCASPAR — Supplemental Application (Servier Pharmaceuticals LLC)
The FDA approved a supplemental application for ONCASPAR (pegaspargase) submitted by Servier Pharmaceuticals LLC.
-
CLINICAL_TRIALS research · 2006-06-26Clinical Trial Update: Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation [Phase 2]
This update covers a Phase 2 trial evaluating single-unit or double-unit cord blood transplantation for hematologic malignancies, including …